Skip to main content
logo
Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.240
-0.130 (-5.49%)
At close: Mar 24, 2026, 4:00 PM EDT
2.316
+0.076 (3.40%)
After-hours: Mar 24, 2026, 7:23 PM EDT

Century Therapeutics Revenue

In the year 2025, Century Therapeutics had annual revenue of $109.16M with 1,556.76% growth.

Revenue (ttm)
$109.16M
Revenue Growth
+1,556.76%
P/S Ratio
3.69
Revenue / Employee
$727,760
Employees
150
Market Cap
402.58M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025109.16M102.58M1,556.76%
Dec 31, 20246.59M4.35M194.81%
Dec 31, 20232.24M-2.96M-57.01%
Dec 31, 20225.20M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals216.11M
REGENXBIO170.44M
Ginkgo Bioworks Holdings170.16M
Invivyd53.43M
Entrada Therapeutics25.42M
Aclaris Therapeutics7.83M
Absci2.82M
Shattuck Labs1.00M
Revenue Rankings

IPSC News

More News